Why is Beta Drugs Ltd falling/rising?

As of 22-Jul, Beta Drugs Ltd is experiencing a decline in its stock price, currently at 1,670.00, which reflects a decrease of 7.65 or 0.46%. The stock has underperformed in the short term, with a 1-week return of -3.47% and a 1-month return of -5.86%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also seen a significant drop of 46.94% compared to the 5-day average, suggesting a decrease in investor participation. Unfortunately, there is no information available regarding positive or negative factors that could further explain the recent movement.
In the broader market context, the stock's performance contrasts with the benchmark, the Sensex, which has only declined by 0.54% over the past week. While Beta Drugs Ltd has outperformed its sector by 0.45% today, its year-to-date performance remains concerning, with a decline of 12.50% compared to the Sensex's increase of 5.99%. This disparity highlights the stock's struggles relative to both its sector and the overall market, contributing to the ongoing downward pressure on its price.